| |
| HEALTHCARE |
Takeda and London School of Hygiene & Tropical Medicine Establish ''Takeda Chair in Global Child Health''
May 18, 2019
(AETOS Wire)-- Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) and the London School of Hygiene & Tropical Medicine (LSHTM) will announce today at the evening reception, hosted by the Embassy of Japan in the United Kingdom, the establishment of the Takeda Chair in Global Child Health, endowed by a £3 million donation by Takeda to LSHTM. The School’s first fully endowed corporate chair, it will support vital research into reducing 5.3 million child deaths in low and middle-income countries. Takeda’s donation will enable LSHTM to recruit a world-class researcher and educator to join its innovative academic team as the first holder of the Takeda Chair in Global Child Health. This post will play a critical role in consolidating LSHTM’s child health research across more than 100 countries, accelerating change for one of the biggest......
German Diabetes Clinic Increases Diabetic Retinopathy Screenings From Zero to Thousands After Implementing Eyenuk’s EyeArt AI Eye Screening System
May 18, 2019
(AETOS Wire) -- Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today results of its expansion into Germany. Since adopting the EyeArt AI Eye Screening System in October 2018, Diabetes Center Mergentheim has screened thousands of diabetic patients, identifying approximately 10% with cases of referable diabetic retinopathy (DR). The center is the first dedicated diabetic clinic in Germany to use artificial intelligence for screening of diabetic retinopathy, the leading cause of vision loss in working-age adults.1 The EyeArt AI Eye Screening System makes in-clinic, real-time DR screening possible for any physician, enabling quick and accurate identification of patients with referable DR during a diabetic patient’s regular physician visit. Once the patient’s......
LifeArc and GVK BIO Celebrate a Decade of Partnership, Transforming Research into Life-Saving Medicines
May 15, 2019
(AETOS Wire)-- GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and LifeArc, one of UK’s top medical research charities, are pleased to announce the 10th anniversary of a successful partnership. The collaboration between LifeArc and GVK BIO brings together two organizations with a singular vision: advancing novel research ideas into potential medicines that can make a significant difference to patients. LifeArc’s"...
Q3 Medical Devices Limited Enters into a Distribution Agreement with Medtronic for its Biodegradable Biliary and Pancreatic Stent
May 15, 2019
(AETOS Wire)-- Q3 Medical Devices Limited (“Q3 Medical”) based in Dublin, Ireland, announced today that it has entered into a distribution agreement with Medtronic plc for ARCHIMEDES, the first to market fully biodegradable biliary and pancreatic stent designed as an alternative to traditional plastic stents. Medtronic’s Gastrointestinal and Hepatology business, which is part of the Minimally"...
Takeda to Highlight New Research into the Long-term Complications of Chronic Hypoparathyroidism at the European Congress of Endocrinology 2019 Annual Meeting
May 15, 2019
(AETOS Wire)-- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it will feature 7 presentations, including one oral presentation, at the upcoming European Congress of Endocrinology (ECE) Annual Meeting from May 18-21, 2019 in Lyon, France. The data presentations include findings from new research into the long-term risks of cardiovascular, renal and infection complications that patients with chronic hypoparathyroidism may experience as well as the latest findings from on-going real world and clinical studies, including the Global Burden of Illness Survey and the 6-year RACE study. Takeda will also sponsor two satellite symposia. The first will focus on the burden of illness in chronic hypoparathyroidism patients with impaired biochemical control and comorbidities associated with the disease (Forum 1 on May 19, 13.45–14.45). The second......
SpeeDx Receives Clearance for PlexPCR Respiratory Virus Test
May 14, 2019
(AETOS Wire) -- SpeeDx Pty. Ltd. today announced the clearance of the PlexPCR® RespiVirus* test from the Australian Therapeutic Goods Administration (TGA). The test utilises market-leading PlexPCR® technology to detect 11 viral respiratory-illness causing pathogens and allows laboratories to process more samples in an 8-hour shift compared to standard in-house test methods. The respiratory virus test includes automated reporting software to further improve laboratory productivity"...
First IVF Baby Born At EVE Fertility Center
May 14, 2019
Doctors at Eve Fertility Center, One of NMC Healthcare Centers in Sharjah, successfully delivered their first baby girl since the clinic’s opening in February earlier this year. Battling infertility for three years, a twenty-six year old resident of Ras-Al-Khaimah, (name withheld on request), was unable to conceive naturally due to male infertility factors. After several failed attempts and almost loosing hope on the thought of having a family of her own, the patient approached IVF specialists at Eve Fertility Center"...
Masimo and Mindray Announce Expanded Partnership
May 13, 2019
Mindray to Offer Masimo SET® Pulse Oximetry in its Patient Monitoring Devices in Additional Countries Beyond the United States (AETOS Wire) -- Masimo (NASDAQ: MASI) and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE: 300760) announced today that they have entered into a purchase and license agreement, under which Mindray will offer Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry – noninvasive, continuous measurement of oxygen saturation (SpO2), pulse rate (PR), and perfusion index (Pi) – in its monitoring devices. Mindray devices equipped with SET® will now be available in select countries in Europe, the Middle East, Russia and the Commonwealth of Independent States, and Asia-Pacific (excluding China), including Australia and India. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190512005059/en/ With the invention of Signal Extraction Technology® (SET®), Masimo established a new standard for pulse oximetry by introducing the ability to......
CosmeSurge Introduces Non-Invasive Body Contouring Treatment
May 13, 2019
Despite rigorous diet and exercise programs, some people struggle with unwanted fat in certain areas. SculpSure, a safe and non-invasive body contouring technique with no reported side effects, can target stubborn fat cells. SculpSure uses lasers to heat fat cells without affecting the skin. Patients feel only a tolerable warm, tingling sensation during the treatment, which lasts approximately 25 minutes. The first session can reduce fat by 25-50%. "...
ABB Wins Major Order to Transmit Wind Power from North Sea
May 10, 2019
(AETOS Wire)-- ABB’s Power Grids business has been awarded a triple digit million-euro order from the Aibel/Keppel FELS consortium, which will design, construct, and build the High Voltage Direct Current (HVDC) transmission system for the offshore wind connection project DolWin5. ABB is the HVDC technology provider. This project will deliver 900 megawatts of zero-carbon electricity – enough to power around 1 million homes - from three wind farms some 100 km off the German"...
|
|
|
|
|